Clinical and genetic study of the first Japanese FTDP-17 patient with a mutation of +3 in intron 10 in the MAPT gene

3Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

Abstract

Frontotemporal dementia with parkinsonism linked to chromosome 17 (FTDP-17) with mutations in the MAPT gene is a hereditary neurodegenerative tauopathy with various clinical phenotypes. We herein report the first Japanese patient with FTDP-17 caused by an IVS10+3G>A mutation in the MAPT gene, which is linked to an H1M haplotype. The present study suggests that the IVS10+3G>A mutation in the MAPT gene can have originated from a non-Caucasian population. In the disease course, myoclonus and respiratory failure can be observed. This study may expand on the clinical and genetic findings for FTDP-17 with mutations in the MAPT gene.

Cite

CITATION STYLE

APA

Nan, H., Takaki, R., Shimozono, K., Ichinose, Y., Koh, K., & Takiyama, Y. (2019). Clinical and genetic study of the first Japanese FTDP-17 patient with a mutation of +3 in intron 10 in the MAPT gene. Internal Medicine, 58(16), 2397–2400. https://doi.org/10.2169/internalmedicine.2761-19

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free